Loading clinical trials...
Loading clinical trials...
Aim: To compare the surgical method of En Bloc resection to the conventional transurethral resection of non-muscle invasive bladder cancer (NMIBC) in terms of complete removal of tumour, specimen qual...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jørgen Bjerggaard Jensen
Collaborators
NCT07206225 · Non-muscle Invasive Bladder Cancer
NCT06510374 · Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06245603 · Non-muscle Invasive Bladder Cancer
NCT03945162 · Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
NCT06781879 · Non-Muscle Invasive Bladder Cancer
Department of Urology, Aalborg University Hospital
Aalborg
Department of Urology, Aarhus University Hospital
Aarhus
Department of Urology, Herlev Hospital
Herlev
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions